However, recent observation of a close correlation between baseline CD34+KDR+ and CD133+KDR+ counts and the outcome of stroke supports the idea that these particular EPC subtypes can be used as potential prognostic markers for ischaemic stroke [91]. This evidence concerns the gene KDR and ischemic stroke.